For more publications, please view the member profiles.
Kim S, Kang H, Skrip L, Sahastrabuddhe S, Islam A, Jung SM, Vesga JF, Endo A, Edmunds WJ, Abbas K. Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response. Expert Review of Vaccines, 24(1):183-193, 2025. https://doi.org/10.1080/14760584.2025.2476523
Anwari P, Burnett E, Chavers TP, Samsor A, Safi H, Safi N, Clark AD, Parashar UD, Tate JE. Post-marketing surveillance of intussusception after Rotarix administration in Afghanistan, 2018-2022. Vaccine, 42(8):2059-2064, 2024. https://doi.org/10.1016/j.vaccine.2024.02.057
Mogasale VV, Sinha A, John J, Hasan Farooqui H, Ray A, Chantler T, Mogasale V, Dhoubhadel BG, Edmunds WJ, Clark A, Abbas K. Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey. BMJ Public Health, 2(2):e001089, 2024. https://doi.org/10.1136/bmjph-2024-001089
Kang H, Auzenbergs M, Clapham H, Maure C, Kim JH, Salje H, Taylor CG, Lim A, Clark A, Edmunds WJ, Sahastrabuddhe S, Brady OJ, Abbas K. Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study. The Lancet Infectious Diseases, S1473-3099(23)00810-1, 2024. https://doi.org/10.1016/S1473-3099(23)00810-1
Giannini F, Cannon JW, Cadarette D, Bloom DE, Moore HC, Carapetis J, Abbas K. Modeling the potential health impact of prospective Strep A vaccines. NPJ Vaccines, 8(1):90, 2023. https://doi.org/10.1038/s41541-023-00668-0
Kim C, Holm M, Frost I, Hasso-Agopsowicz M, Abbas K. Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study. BMJ Global Health, 8(7):e011341, 2023. https://doi.org/10.1136/bmjgh-2022-011341
Kobayashi T, Tomoi H, Nishina Y, Harada K, Tanaka K, Sasaki S, Inaba K, Mitaka H, Takahashi H, Passanante A, Lau EHY, Naito T, Larson H, Wu J, Lin L, Yamada Y. Effect of a mobile app chatbot and an interactive small-group webinar on COVID-19 vaccine intention and confidence in Japan: a randomised controlled trial. BMJ Global Health, 8(5):e010370, 2023. https://doi.org/10.1136/bmjgh-2022-010370
Khongyot T, Moriyasu T. Invasive Pneumococcal Disease diminish during the onset of COVID-19 in Japan between 2019 and 2022. International Journal of Infectious Diseases, 122:307-309, 2022. https://doi.org/10.1016/j.ijid.2022.05.064
Hasan AZ, Kumar MS, Prosperi C, Thangaraj JWV, Sabarinathan R, Saravanakumar V, Duraiswamy A, Kaduskar O, Bhatt V, Deshpande GR, Ullas PT, Sapkal GN, Sangal L, Mehendale SM, Gupta N, Moss WJ, Hayford K, Murhekar MV; IMRVI Study Group. Implementing serosurveys in India: experiences, lessons learned, and recommendations. American Journal of Tropical Medicine and Hygiene, 105(6):1608-1617, 2021. https://doi.org/10.4269/ajtmh.21-0401
Mogasale VV, Saldanha P, Pai V, Rekha PD, Mogasale V. A descriptive analysis of antimicrobial resistance patterns of WHO priority pathogens isolated in children from a tertiary care hospital in India. Scientific Reports, Mar 4;11(1):5116, 2021. https://doi.org/10.1038/s41598-021-84293-8